Under construction – not a live service
Sign in
Taking people in SerbiaNo phase

Building AI tools to predict abdominal aortic aneurysm and leg artery disease

Develops AI tools to predict disease progression in people with aneurysm or artery disease.

Key facts

Who runs it
Amsterdam UMC, location VUmc
Where
Belgrade, SerbiaSee the siteAlso in 5 other countries, 5 sites
Trial code
Registry title
Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression
Status
Recruiting
People taking part
11,000 people, planned
Started
31 Oct 2023
Expected to end
1 May 2029
Type of study
Observational, 2 groups
Treatments tested
  • No intervention, retrospective study
Record updated
5 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with an abdominal aortic aneurysm (a bulge in the main belly artery) or peripheral arterial disease (narrowed leg arteries). It uses existing patient data to build AI tools.

Age
40-90 years old
Sex
Males and females
Disease stage
Aneurysm group: infrarenal, juxtarenal, suprarenal, iliac or mycotic aneurysms, with a starting diameter >3cm (1.2 in). PAD group: all Fontaine stages 1, 2, 3 and 4.
Earlier treatment
Aneurysm patients can join whether or not they have had interventions or ruptures.

Main reasons for not taking part

  • People with only an ascending, thoracic or thoracoabdominal (type 1-3) aneurysm cannot join the aneurysm group.

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Males and females
  • 40-90 years old,
  • Infrarenal, juxtarenal, suprarenal, iliac aneurysms (defined as 1.5x its normal diameter), and mycotic aneurysms
  • Starting AAA diameter >3cm,
  • Patients that both have had or did not have interventions or ruptures
  • Males and females,
  • 40-90 years old,
  • All PAD patients; all Fontaine stages 1,2,3, and 4

Who cannot take part

  • Patients with solely an ascending, thoracic, thoracoabdominal (type 1-3) aneurysm

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 40 and 90 years old?

Where in Serbia

Also in 5 other countries, 5 sites

  • University Clinical Centre of SerbiaBelgrade, SerbiaContact: Igor KoncarTaking people

About the trial

What the trial wants to find out

The VASCULAID-RETRO study, within the broader VASCULAID project, aims to create artificial intelligence (AI) algorithms that can predict cardiovascular events and the progression of abdominal aortic aneurysm (AAA) and peripheral arterial disease (PAD). The study plans to gather and analyze data from at least 5000 AAA and 6000 PAD patients, combining existing cohorts and retrospectively collected data. During this project, AI tools will be developed to perform automatic anatomical segmentation and analyses on multimodal imaging. AI prediction algorithms will be developed based on multisource data (imaging, medical history, -omics).

The 2 groups in the trial

  • Abdominal Aortic Aneurysm patients

    Treatment: No intervention, retrospective study

  • Peripheral Arterial Disease patients

    Treatment: No intervention, retrospective study

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression
Plain-language title
Building AI tools to predict abdominal aortic aneurysm and leg artery diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT06206369, who can take part
Record updated
5 October 2026